AAAAAA
Results:
1-13
|
Results: 13
Authors:
Corpechot, C
Benlian, P
Barbu, V
Chazouilleres, O
Poupon, RE
Poupon, R
Citation: C. Corpechot et al., Apolipoprotein E polymorphism, a marker of disease severity in primary biliary cirrhosis?, J HEPATOL, 35(3), 2001, pp. 324-328
Authors:
Poupon, R
Poupon, RE
Citation: R. Poupon et Re. Poupon, Treatment of primary biliary cirrhosis, BEST PR RES, 14(4), 2000, pp. 615-628
Authors:
Corpechot, C
Carrat, F
Bonnand, AM
Poupon, RE
Poupon, R
Citation: C. Corpechot et al., The effect of ursodeoxycholic acid therapy on liver fibrosis progression in primary biliary cirrhosis, HEPATOLOGY, 32(6), 2000, pp. 1196-1199
Authors:
Poupon, RE
Citation: Re. Poupon, Ursodeoxycholic acid for primary biliary cirrhosis: lessons from the past - issues for the future, J HEPATOL, 32(4), 2000, pp. 685-688
Authors:
Guechot, J
Serfaty, L
Bonnand, AM
Chazouilleres, O
Poupon, RE
Poupon, R
Citation: J. Guechot et al., Prognostic value of serum hyaluronan in patients with compensated HCV cirrhosis, J HEPATOL, 32(3), 2000, pp. 447-452
Authors:
Poupon, R
Chazouilleres, O
Poupon, RE
Citation: R. Poupon et al., Chronic cholestatic diseases, J HEPATOL, 32, 2000, pp. 129-140
Authors:
Fontaine, H
Thiers, V
Chretien, Y
Zylberberg, H
Poupon, RE
Brechot, C
Legendre, C
Kreis, H
Pol, S
Citation: H. Fontaine et al., HBV genotypic resistance to lamivudine in kidney recipients and hemodialyzed patients, TRANSPLANT, 69(10), 2000, pp. 2090-2094
Authors:
Poupon, RE
Bonnand, AM
Queneau, PE
Trepo, C
Zarski, JP
Vetter, D
Raabe, JJ
Thieffin, G
Larrey, D
Grange, JD
Capron, JP
Serfaty, L
Chretien, Y
Girardin, MFS
Mathiex-Fortunet, H
Zafrani, ES
Guechot, J
Beuers, U
Paumgartner, G
Poupon, R
Citation: Re. Poupon et al., Randomized trial of interferon-alpha plus ursodeoxycholic acid versus interferon plus placebo in patients with chronic hepatitis C resistant to interferon, SC J GASTR, 35(6), 2000, pp. 642-649
Authors:
Heathcote, EJ
Stone, J
Cauch-Dudek, K
Poupon, R
Chazouilleres, O
Lindor, KD
Petz, J
Dickson, ER
Poupon, RE
Citation: Ej. Heathcote et al., Effect of pretransplantation ursodeoxycholic acid therapy on the outcome of liver transplantation in patients with primary biliary cirrhosis, LIVER TR S, 5(4), 1999, pp. 269-274
Authors:
Poupon, RE
Bonnand, AM
Chretien, Y
Poupon, R
Citation: Re. Poupon et al., Ten-year survival in ursodeoxycholic acid-treated patients with primary biliary cirrhosis, HEPATOLOGY, 29(6), 1999, pp. 1668-1671
Authors:
Degott, C
Zafrani, ES
Callard, P
Balkau, B
Poupon, RE
Poupon, R
Citation: C. Degott et al., Histopathological study of primary biliary cirrhosis and the effect of ursodeoxycholic acid treatment on histology progression, HEPATOLOGY, 29(4), 1999, pp. 1007-1012
Authors:
Bonnand, AM
Heathcote, EJ
Lindor, KD
Poupon, RE
Citation: Am. Bonnand et al., Clinical significance of serum bilirubin levels under ursodeoxycholic acidtherapy in patients with primary biliary cirrhosis, HEPATOLOGY, 29(1), 1999, pp. 39-43
Authors:
Poupon, R
Chazouilleres, O
Balkau, B
Poupon, RE
Citation: R. Poupon et al., Clinical and biochemical expression of the histopathological lesions of primary biliary cirrhosis, J HEPATOL, 30(3), 1999, pp. 408-412
Risultati:
1-13
|